IUSM's Precision Health Initiative is first recipient of Grand Challenges fund
IU announced that the Precision Health Initiative, a research endeavor focused on patient-centered precision medicine therapies and led by IU School of Medicine faculty, will receive the first funding under the university’s new $300 million Grand Challenges Program.
The Precision Health Initiative will develop IU’s expertise in individualized precision medicine with team members working closely with several prominent business and community partners, including Eli Lilly and Company, Roche Diagnostics, Cook Regentec, Deloitte, Regenstrief Institute, and Indiana University Health.
IU President Michael A. McRobbie said the Precision Health Initiative is a visionary proposal that fully realizes the vision of IU’s Bicentennial Strategic Plan to improve the education, health, economy, and quality of life of the people of Indiana. Led by IU Associate Vice President for Clinical Affairs and IU School of Medicine Executive Associate Dean for Research Affairs Anantha Shekhar, the Precision Health Initiative will seek to cure at least one cancer and one childhood disease, as well as find ways to prevent one chronic illness and one neurodegenerative disease.Read more